Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06683963

AI-Assisted TelerehabiLitAtion System (ATLAS) for Post-discharge Continuation of Rehabilitative Care

The study team proposes ATLAS (AI-Assisted TelerehabiLitAtion System) a two-part solution. The first-Rebee AI-assisted telerehabilitation device-assists in inpatient rehabilitation, and allows patients to continue with their physical rehabilitation when discharged and waiting for Day Rehabilitation Centre (DRC). The second-a structured programme to train and familiarise patients and caregivers to Rebee over patients' Community Hospital (CH) inpatient rehabilitation stay-adopts an evidence-based approach to increase uptake and adherence to Rebee.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Rehabilitation Deconditioning

Age range

60 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Rehabilitation Diagnostic Group (RDG): Total Knee Replacement / Deconditioning
  • Age 60 and above
  • Speak English/Mandarin
  • Able to follow instructions, no cognitive impairment
  • No MDRO (MultiDrug Resistant Organism)
  • Suitable and able to wear motion sensor on upper and lower limbs
  • Suitable and able to engage in Rebee exercises

Exclusion criteria

  • Not under RDG: Total Knee Replacement / Deconditioning
  • Below 60 years old
  • Unable to speak English/Mandarin
  • Cognitive impaired, unable to follow instructions
  • Has MDRO
  • Not suitable to wear motion sensor on upper and lower limbs
  • Refusal to participate / give informed consent

Treatment and study plan

Rebee

Device

Tablet device with accompanying sensor device. Tablet device is preloaded with exercises, to be taught to patients during their hospital stay, and to be continued post-discharge

Primary outcomes

  1. Change in Modified Barthel Index scores from baseline to 4, 8, and 12 weeks

    Time frame: from recruitment (week 0) till end of study at 12 weeks

    Modified Barthel Index (MBI) measures ability to complete activities of daily living (ADLs).

    Scores range from 0 to 100. A higher score represents more independence, a lower score indicates more assistance needed (ie less independent).

    0-20: Total dependence, 21-60: Severe dependence, 61-90: Moderate dependence, 91-99: Slight dependence, 100: Independence.

Secondary outcomes

  1. Change in Quality of Life scores from baseline to 4, 8, and 12 weeks

    Time frame: from recruitment (week 0) till end of study at 12 weeks

    Quality of Life as measured using EQ-5D-5L.

    Has two components to this instrument:

    • EQ-5D descriptive system
    • 1 to 5 for each dimension
    • A higher score represents "worse health status" (i.e., more severe problems with dimension).
    • EQ visual analogue scale (EQ VAS)
    • 0 to 100
    • A higher score represents "better health status" (i.e., overall current health status).

  2. Change in Patient Activation Level from baseline to 4, 8, and 12 weeks

    Time frame: from recruitment (week 0) till end of study at 12 weeks

    Patient Activation Level measured using PAM-13 Score from 0 to 100 Higher scores indicate greater patient activation

  3. Readmission rates to hospital within 30 days of discharge

    Time frame: within 30 days from discharge date

    e.g. 0 means no readmissions back to hospital within 30 days of discharge occured

  4. Change in Joint range of motion from baseline to 4, 8, and 12 weeks

    Time frame: from recruitment (week 0) till end of study at 12 weeks

    Measured Joint Range of operated knee for patients with total knee replacement (TKR) Joint range will be measured for knee Extension and well as knee Flexion

  5. Length of Stay in Community Hospital reported in days

    Time frame: From recruitment (week 0) till end of study at 12 weeks

    Length of (inpatient) Stay in Community Hospital Reported in days, as measured by Discharge Date minus Admission Date e.g. if Discharge Date is 3/11/2024, and Admission Date is 1/11/2024, patient stayed for 2 days as an inpatient in the community hospital

  6. Change in STS (sit to stand) score from baseline to 4, 8, and 12 weeks

    Time frame: from recruitment (week 0) till end of study at 12 weeks

    Time taken to Sit to Stand 5 times, calculated in seconds A higher score represents taking a longer time to complete 5 times sit to stand.

Study contacts

Contact information is provided by the study sponsor or research team.

Charmaine Tan

CONTACT

[email protected]

+6569703029

Lian Leng Low

CONTACT

[email protected]

+6563265872

Sponsors and collaborators

Lead sponsor

SingHealth Community Hospitals

Other

Collaborators

  • Jurong Community Hospital
  • Rebee Health

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Nov 12, 2024
Registry last updated
Nov 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.